Published in Recomb DNA Tech Bull on April 01, 1981
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Resolutions and identification of the core deoxynucleoproteins of the simian virus 40. Biochem Biophys Res Commun (1973) 2.90
Structural proteins of simian virus 40. J Virol (1971) 1.91
Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice. Int J Cancer (1972) 1.70
Murine C-type RNA virus from spontaneous neoplasms: in vitro host range and oncogenic potential. Science (1973) 1.48
Embryonic stem cells and transgenic mice ubiquitously expressing a tau-tagged green fluorescent protein. Dev Biol (2000) 1.41
Food irradiation--promising technology for public health. Public Health Rep (1992) 1.39
The transcription factor, Pax6, is required for cell proliferation and differentiation in the developing cerebral cortex. Cereb Cortex (1999) 1.32
Experimental infection of calves with hemadsorbing enteric (HADEN) virus. Cornell Vet (1966) 1.18
A role for Pax6 in the normal development of dorsal thalamus and its cortical connections. Development (2000) 1.16
Reducing infant mortality in the United States through "Healthy Start". Public Health Rep (1991) 1.13
A novel cytochrome P450 expressed primarily in brain. J Biol Chem (1995) 1.10
Neoplasm induction by murine type-C viruses passaged directly from spontaneous non-lymphoreticular tumours. Nat New Biol (1973) 1.02
Incidence of spontaneous neoplasms in breeding and retired breeder BALB-cCr mice throughout the natural life span. Int J Cancer (1972) 1.01
Interaction of Wnt-1 proteins with the binding protein BiP. Mol Cell Biol (1992) 1.00
Physical activity, behavioral epidemiology, and public health. Public Health Rep (1985) 0.97
An improved method for enumeration of X-C cell assay for murine leukemia virus. Appl Microbiol (1973) 0.96
Oncogenic potential of murine C-type RNA virus passaged directly from naturally occurring tumors of the BALB-cCr mouse. J Natl Cancer Inst (1973) 0.93
Characteristics of hemadsorbing enteric (HADEN) virus. Can J Microbiol (1966) 0.92
Opportunities for the elimination of tuberculosis. Am Rev Respir Dis (1986) 0.92
The use of asbestos-cement pipe for public water supply and the incidence of cancer in selected communities in Utah. J Community Health (1984) 0.91
Investigations of survival properties of airborne murine leukemia virus. J Natl Cancer Inst (1970) 0.90
Streptonigrin inhibition of 3-methylcholanthrene transformation in vitro. Proc Soc Exp Biol Med (1974) 0.88
Spontaneous tumors and pathologic lesions in SWR-J mice. J Natl Cancer Inst (1973) 0.87
Mouse Wnt8B is expressed in the developing forebrain and maps to chromosome 19. Mamm Genome (1999) 0.86
The prevention and control of chronic diseases: reducing unnecessary deaths and disability--a conference report. Public Health Rep (1987) 0.84
Expression and genomic characterization of protein phosphatase inhibitor-1: a novel marker for mesothelium in the mouse. Mech Dev (2000) 0.83
Electrophoretic differences in the capsid proteins of simian virus 40 plaque mutants. J Virol (1973) 0.83
Scientific integrity. Science (1990) 0.82
Identifying GFP-transgenic animals by flashlight. Biotechniques (2003) 0.82
Office of scientific integrity. Science (1989) 0.81
Designing a National Disaster Medical System. Public Health Rep (1985) 0.81
Analysis of simian virus 40 wild-type and mutant virions by agarose gel electrophoresis. J Virol (1976) 0.81
Enhancement of Friend leukemia virus infection in mice by Guaroa virus: quantitation and action of various oncogenic and nononcogenic viruses. Appl Microbiol (1970) 0.81
Incidence of group-specific (gs) antigens of type C tumor viruses in spontaneous neoplasms of BALB-cCr mice. Int J Cancer (1972) 0.80
Understanding the disparities in morbidity and mortality among racial and ethnic groups in the United States. Ann Epidemiol (1993) 0.80
Enteric disease and health for all: a public health perspective. Pediatr Infect Dis (1986) 0.79
Intraocular blastomycosis: case report and review. Clin Infect Dis (1994) 0.79
Pentobarbital and thiopental anesthetic interactions with midazolam. Anesthesiology (1987) 0.79
Interferon mediates enhancement of tumour growth and virus-induced sarcomas in mice. Nat New Biol (1973) 0.79
Health progress in the United States. Results of the 1990 objectives for the nation. JAMA (1992) 0.78
Personal health promotion. West J Med (1984) 0.78
Transformation of Fischer rat embryo cells by the combined action of murine leukemia virus and (-)-trans- 9 -tetrahydrocannabinol. Proc Soc Exp Biol Med (1972) 0.77
Central serous retinopathy following long-duration laser pointer exposure. South Med J (2001) 0.77
Differential inhibitory effects of interferon on deoxythymidine kinase induction of vaccinia-infected cell cultures. Proc Soc Exp Biol Med (1968) 0.76
Geldanamycin inhibition of 3-methylcholanthrene-induced rat embryo cell transformation. Proc Soc Exp Biol Med (1977) 0.76
Improving the health of minorities. Public Health Rep (1990) 0.75
Sensitive in vivo assay for detection of murine leukemia viruses. Appl Microbiol (1974) 0.75
Physicians and disaster preparedness. JAMA (1992) 0.75
A positive approach to smoking prevention and cessation. West J Med (1983) 0.75
From the Assistant Secretary for Health. JAMA (1989) 0.75
A prevention policy framework for the nation. Health Aff (Millwood) (1990) 0.75
From the Health Care Financing Administration. JAMA (1992) 0.75
Prevention 'goal' of CDC programs. US Med (1984) 0.75
From the Assistant Secretary for Health, US Public Health Service. JAMA (1991) 0.75
From the Assistant Secretary for Health. JAMA (1989) 0.75
Statement on the development of guidelines for the prevention of AIDS transmission in the workplace. Public Health Rep (1986) 0.75
The dimensions of an epidemic of violence. Public Health Rep (1993) 0.75
The management of supraspinatus tendinitis in general practice. Ir Med J (1980) 0.75
Subconjunctival miconazole and anterior segment blastomycosis. Am J Ophthalmol (1993) 0.75
Morphine and fentanyl hypnotic interactions with thiopental. Anesthesiology (1987) 0.75
Vaccine supply and liability. Public Health Rep (1986) 0.75
From the Assistant Secretary for Health. JAMA (1990) 0.75
Healthy people 2000: the challenge to academic medicine. Acad Med (1991) 0.75
Closing the gaps in public health. The health status of racial and ethnic minorities. Vital Speeches Day (1986) 0.75
Health care in the U.S.: facts and choices. Second Opin (1990) 0.75
The health of African Americans: special emphasis on kidney disease. Am J Kidney Dis (1993) 0.75
Enhancement of in vitro transformation by polyinosinic-polycytidylic acid. J Natl Cancer Inst (1973) 0.75
Pneumocystis and mucormycosis pneumonitis. Chest (1970) 0.75
Today's challenges to the Public Health Service and to the nation. Public Health Rep (1991) 0.75
Healthy people in 2000. Am Fam Physician (1990) 0.75
Employers' role in preventing disease. Interview by Jane Stein. Bus Health (1987) 0.75
Inducible transgene expression in undifferentiated mouse embryonic stem cells and embryoid bodies. Med J Malaysia (2008) 0.75
Morphine and fentanyl interactions with thiopental in relation to movement response to noxious stimulation. Anesth Analg (1986) 0.75
Barbiturates inhibit stress-induced analgesia. Can J Anaesth (1987) 0.75
The role of school health. J Sch Health (1985) 0.75
Dr. Mason outlines goals for improving the nation's health. J Sch Health (1989) 0.75
Differential action of hormones on induced resistance to 2-deoxy-D-glucose in mammalian cell cultures. Biochim Biophys Acta (1966) 0.75
What's ahead for the Public Health Service?. Interview by Janice C. Simmons. Internist (1990) 0.75
Addressing the measles epidemic. Public Health Rep (1992) 0.75
Virogenic properties of AKR mouse sarcoma cells induced by rous sarcoma virus. Arch Gesamte Virusforsch (1973) 0.75